BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

N/A
indicator

Bse 500

1D
1M
3M
6M
1Y
5Y
empty graph

Bse 500 Performance

Day's Range

Low

₹35,827.13

High

₹35,887.56

52 Week Range

Low

₹31,965.51

High

₹37,874.46

Previous Close ₹35,831.60
Day's Range ₹35,827.13 - ₹35,887.56
Open ₹35,827.86
52 Week Range ₹31,965.51 - ₹37,874.46
Volume 5,82,38,479

Bse 500 Companies

Company Name LTP (₹) Change (₹) Sector
ABB India Ltd. 7385.50 Arrow 114.55 (1.58%) Capital Goods
Aegis Logistics Ltd. 1498.70 Arrow 11.95 (0.80%) Trading
Amara Raja Energy & Mobility Ltd. 806.15 Arrow 11.40 (1.43%) Automobile & Ancillaries
Atul Ltd. 6150.55 Arrow 61.70 (1.01%) Chemicals
Force Motors Ltd. 17535.00 Arrow 37.00 (0.21%) Automobile & Ancillaries
Bajaj Finance Ltd. 1024.80 Arrow 0.80 (0.08%) Finance
Balrampur Chini Mills Ltd. 656.65 Arrow -6.90 (-1.04%) Agri
Aditya Birla Real Estate Ltd. 1241.95 Arrow 2.25 (0.18%) Realty
Bata India Ltd. 637.50 Arrow 2.65 (0.42%) FMCG
BEML Ltd. 2093.05 Arrow -4.75 (-0.23%) Capital Goods

All Indices

Index Name Market Value 52W High 52W Low
Nifty 50 23446.5 26373.20 22182.55
Nifty IT 28512.65 40301.40 25699.10
Nifty Next 50 72298.75 75000.40 59896.10
NIFTY50 USD Index 8490.7 10443.40 8132.40
Nifty Bank 56571.75 61764.85 49954.85
NIFTY Midcap 100 62188.5 64450.90 52032.85
Nifty 500 22910.15 24144.20 20385.65
Nifty Midcap 50 17922.4 18500.95 14804.55
Nifty 100 24601.55 26975.15 22720.45
Nifty FMCG 45925.5 57445.20 44825.60

Latest News

Sep
21
2026
EQUITY Posted on Sep 21st 2026

Jindal Saw informs about credit rating

Jindal Saw has informed that CARE Ratings vide its letters dated September 18, 2026 reaffirmed the credit rating for various instruments/banking facilities of the Company. Copies of said letters are attached.
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
21
2026
EQUITY Posted on Sep 21st 2026

Piramal Finance informs about analyst meet

Pursuant to Regulation 30(6) of the SEBI Listing Regulations, Piramal Finance has informed that it enclosed the schedule of Analyst/Institutional Investor Meeting scheduled on 28th September 2026. Further, the investor presentation to be made at above mentioned conference is also enclosed.
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
21
2026
EQUITY Posted on Sep 21st 2026

National Securities Depository informs about updates

National Securities Depository has informed that in compliance with Regulation 30 of the SEBI Listing Regulations and in furtherance to our intimation dated May 25, 2026, and pursuant to the approval of SEBI vide letter no. HO/47/22/16(2)2026-MRD-RAC2-I/12350/2026 dated May 25, 2026, and based on approvals of the Nomination and Remuneration Committee and the Governing Board at their respective meeting held on June 03, 2026, Ankit Sharma (DIN: 10496270) has joined as Executive Director - Vertical 2 (Regulatory, Compliance, Risk Management & Investor Grievances) on the Governing Board of NSDL for a period of five (5) years effective from today i.e. September 21, 2026. Relevant details in terms of Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/l/3762/2026 dated January 30, 2026, is enclosed as Annexure. 
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
21
2026
EQUITY Posted on Sep 21st 2026

Cohance Lifesciences informs about update

Cohance Lifesciences has informed that the United States Food and Drug Administration (USFDA) inspected the Company’s API manufacturing facility at Jaggaiahpet, Andhra Pradesh, India (FEI No. 3005554260), from 14 September to 19 September 2026. The inspection concluded with the issuance of a Form FDA 483 containing five observations. The Company has initiated appropriate corrective and preventive actions (CAPA) and will submit its response within the stipulated timeline. The Company remains committed to quality and regulatory compliance.
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
21
2026
EQUITY Posted on Sep 21st 2026

Glenmark Pharmaceuticals informs about analyst meet

Pursuant to the Regulation 30 and Para A of Part A of Schedule III of the SEBI LODR, Glenmark Pharmaceuticals has informed that the company will be meeting Investor/Analyst (Participants) in PL Capital - Emerging Titans 2026 Conference on 29-09-2026. No unpublished price sensitive information is proposed to be shared during the meeting. 
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Frequently Asked Questions

What is the Previous Close of BSE500 index?

The previous close of BSE500 index is ₹35831.6 as of 2026-09-22.

The total volume of BSE500 index is 58238479.00 as of 2026-09-22.

The percentage change in value of BSE500 index is 0.12% as of 2026-09-22.

The absolute increase in BSE500 index value since the previous trading day is ₹43.96 as of 2026-09-22.

A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.

View More
Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore